WallStreetZenWallStreetZen

NASDAQ: RNTX
Rein Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Rein Therapeutics earnings were -$62.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RNTX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$41.0M, up 600.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RNTX reported annual earnings of -$62.9M, with 299.7% growth.

RNTX earnings history

Current Revenue
$0.0
Current Earnings
-$62.9M
Current Profit Margin
0%

RNTX Return on Equity

Current Company
-73.6%
Current Industry
-2%
Current Market
34.1%
RNTX's Return on Equity (-73.6%)... subscribe to Premium to read more.
High Return on Equity Performance

RNTX undefined

Current Company
-67.1%
Current Industry
-0.4%
RNTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RNTX announces earnings.

RNTX undefined

Current Company
-114.15%
Current Industry
5.9%
RNTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RNTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RNTX-$64.36M-$62.88MN/A-$3.51
RVPH-$29.88M-$29.92MN/A-$0.90
HOWL-$63.16M-$70.52MN/A-$1.63
CAMP-$48.35M-$51.79MN/A-$11.04
XLO-$56.60M-$58.24MN/A-$1.09
View Top Biotech Stocks

Rein Therapeutics Earnings Reports & History FAQ

What were Rein Therapeutics's earnings last quarter?

On RNTX's earnings call on Invalid Date, Rein Therapeutics (NASDAQ: RNTX) reported Q4 2024 earnings per share (EPS) of -$2.20, up 40.13% year over year. Total RNTX earnings for the quarter were -$40.98 million. In the same quarter last year, Rein Therapeutics's earnings per share (EPS) was -$1.57.

If you're new to stock investing, here's how to buy Rein Therapeutics stock.

Is Rein Therapeutics profitable or losing money?

As of the last Rein Therapeutics earnings report, Rein Therapeutics is currently losing money. Rein Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$62.88 million, a 299.71% increase year over year.

What was RNTX's earnings growth in the past year?

As of Rein Therapeutics's earnings date in Invalid Date, Rein Therapeutics's earnings has grown year over year. RNTX earnings in the past year totalled -$62.88 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.